Chang JI

No ORCID on file · 1 paper in corpus

case-report 2016

Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report

Journal of medical case reports ·doi:10.1186/s13256-016-1110-5

BACKGROUND: The treatment options for high-risk prostate cancer are either radical prostatectomy or radiotherapy/brachytherapy depending on the patients' prognosis. In older men with multiple comorbidities, radiotherapy with androgen depriv…